Showing 9 posts of 54 posts found.

Onglyza cleared for use with insulin

November 29, 2011
Sales and Marketing AstraZeneca, Merck, Onglyza, diabetes, insulin

European regulators have approved a licence extension for Bristol-Myers Squibb and AstraZeneca’s type II diabetes treatment Onglyza. The oral DPP-4 …

NHS ‘wasted’ £625 million on modern insulin

September 23, 2011
Sales and Marketing diabetes, insulin

The NHS has wasted £625 million on modern insulin products over the last decade, according to a new report in …

Afrezza could breathe new life into inhaled insulin market

August 15, 2011
Research and Development, Sales and Marketing diabetes, inhaled insulin, insulin, research and development news

New trials for MannKind’s investigational inhaled insulin drug Afrezza have been given the go-ahead by the FDA, potentially breathing new …

Treatment flexibility will improve adherence in diabetes, study suggests

June 29, 2011
Research and Development, Sales and Marketing diabetes, insulin

A third of patients with diabetes admit to regularly missing or not taking insulin treatment three days a month, according …

Novo Nordisk headquarters

New product can overtake Lantus, says Novo leader

May 11, 2011
Sales and Marketing Novo Nordisk, degludec, diabetes, insulin

Novo Nordisk’s new insulin product can eclipse Sanofi’s Lantus within just a few years of its launch, according to Novo’s …

Novo to develop oral insulin

December 22, 2010
Research and Development Emisphere, Novo Nordisk, diabetes, insulin, oral insulin, type I diabetes

Novo Nordisk is to develop an oral formulation of insulin with US biotech company Emisphere Technologies. The New Jersey-based biotech …

Merck acquires innovative insulin firm SmartCells

December 3, 2010
Research and Development Merck, Merck & Co, SmartCells, diabetes, insulin

Merck has bolstered its early stage diabetes portfolio with the acquisition of SmartCells, a private pharma firm that’s developing a …

Novo Nordisk invests $73m to boost diabetes drug production

October 8, 2010
Manufacturing and Production Novo Nordisk, diabetes, insulin

Novo Nordisk has announced another major expansion of its manufacturing capacity for diabetes products, setting aside $73 million to expand …

Novo agrees price cut deal with Greece

June 16, 2010
Sales and Marketing Greece, Novo Nordisk, insulin, pricing

Novo Nordisk has agreed to resume supply of its insulins to the Greek market after pulling them last month as …

Latest content